Compass Therapeutics, Inc.
CMPX
$2.25
-$0.01-0.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -25.15M | -18.32M | -15.72M | -14.26M | -19.88M |
| Total Depreciation and Amortization | 376.00K | 368.00K | 370.00K | 371.00K | 367.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.62M | 4.87M | 629.00K | 863.00K | 2.66M |
| Change in Net Operating Assets | 5.42M | -4.19M | 1.46M | 2.18M | 5.02M |
| Cash from Operations | -14.74M | -17.27M | -13.25M | -10.85M | -11.83M |
| Capital Expenditure | -176.00K | -82.00K | 0.00 | -7.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.80M | 38.51M | -3.38M | -95.15M | -6.36M |
| Cash from Investing | -4.98M | 38.43M | -3.38M | -95.16M | -6.36M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 3.85M | 1.28M | 138.00M | -- |
| Repurchase of Common Stock | 0.00 | -489.00K | -212.00K | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -8.64M | -- |
| Cash from Financing | 0.00 | 3.37M | 1.06M | 129.36M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.72M | 24.53M | -15.57M | 23.36M | -18.19M |